Treatment with Bimagrumab safe for patients with obesity, diabetes
Bimagrumab is an antibody that blocks activ in type II receptors and stimulates skeletal muscle growth
Thursday January 14, 2021 12:14 PM, IANS
New York: Researchers have found that treatment with Bimagrumab is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and Type-2 diabetes.
Bimagrumab is an antibody that blocks activ in type II receptors and stimulates skeletal muscle growth.
"These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits," said researcher Steve Heymsfield from Pennington Biomedical Research Center, in the US.